Stage IV Melanoma Active Not Recruiting Phase 1 Trials for Selicrelumab (DB14958)

IndicationStatusPhase
DBCOND0028660 (Stage IV Melanoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01103635Tremelimumab and CP-870,893 in Patients With Metastatic MelanomaTreatment